These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34370070)

  • 1. In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana.
    Blanco Z; Mijares MR; Ramírez H; Fernandez-Moreira E; Oviedo HJ; Rodríguez NM; Charris JE
    Parasitol Res; 2021 Sep; 120(9):3307-3317. PubMed ID: 34370070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and leishmanicidal evaluation of sulfanyl- and sulfonyl-tethered functionalized benzoate derivatives featuring a nitroimidazole moiety.
    Rodríguez M; Gutiérrez J; Domínguez J; Peixoto PA; Fernández A; Rodríguez N; Deffieux D; Rojas L; Quideau S; Pouységu L; Charris J
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000002. PubMed ID: 32180262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a juvenile hormone analogue on Leishmania amazonensis and Leishmania braziliensis.
    Esteva M; Maidana C; Sinagra A; Luna C; Ruiz AM; Stoka AM
    Exp Parasitol; 2005 Jun; 110(2):162-4. PubMed ID: 15888299
    [No Abstract]   [Full Text] [Related]  

  • 5. Antileismanial activity, mechanism of action study and molecular docking of 1,4-bis(substituted benzalhydrazino)phthalazines.
    Romero AH; Rodríguez N; Oviedo H; Lopez SE
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800299. PubMed ID: 31012160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model.
    Sinagra A; Luna C; Abraham D; Iannella Mdel C; Riarte A; Krolewiecki AJ
    Rev Soc Bras Med Trop; 2007; 40(6):627-30. PubMed ID: 18200413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania species.
    de Morais-Teixeira E; Rabello A; Aguiar MMG
    J Antimicrob Chemother; 2019 Aug; 74(8):2318-2325. PubMed ID: 31049550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes.
    Rangel H; Dagger F; Hernandez A; Liendo A; Urbina JA
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2785-91. PubMed ID: 9124841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
    Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmaniasis in the major endemic region of Plurinational State of Bolivia: Species identification, phylogeography and drug susceptibility implications.
    Bilbao-Ramos P; Dea-Ayuela MA; Cardenas-Alegría O; Salamanca E; Santalla-Vargas JA; Benito C; Flores N; Bolás-Fernández F
    Acta Trop; 2017 Dec; 176():150-161. PubMed ID: 28751163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
    de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
    J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities.
    Martinez S; Looker DL; Marr JJ
    Am J Trop Med Hyg; 1988 Mar; 38(2):304-7. PubMed ID: 2833127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis.
    Van Bocxlaer K; Caridha D; Black C; Vesely B; Leed S; Sciotti RJ; Wijnant GJ; Yardley V; Braillard S; Mowbray CE; Ioset JR; Croft SL
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():129-138. PubMed ID: 30922847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betulin derivatives impair Leishmania braziliensis viability and host-parasite interaction.
    Alcazar W; López AS; Alakurtti S; Tuononen ML; Yli-Kauhaluoma J; Ponte-Sucre A
    Bioorg Med Chem; 2014 Nov; 22(21):6220-6. PubMed ID: 25240731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.